Quick Answer
Curanex Pharmaceuticals Inc reported Net Income Loss of -$4.23 million for the year ending 2025.
- Curanex Pharmaceuticals Inc showed a decrease of -1,068.8% in Net Income Loss from 2024 to 2025.
- This data is from Curanex Pharmaceuticals Inc's annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2024 to 2025 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2024: -$80.2 thousand | Q2 2024: -$44.2 thousand | Q3 2024: -$91.2 thousand | Q1 2025: -$137.6 thousand | Q2 2025: -$60.3 thousand | Q3 2025: -$954.1 thousand.
- Historical annual values: Fiscal year 2025: -$4.23 million | Fiscal year 2024: -$361.5 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: